Yaz Lawsuit Archives - Carey Danis & Lowe

Yaz Lawsuit Filed in Texas Federal Court

By | Pharmaceutical litigation, Uncategorized, Yaz/Yasmin

yaz_lawsuitA plaintiff who suffered from more than one pulmonary embolism filed a Yaz lawsuit in a federal court in Texas in late December. According to The Southeast Texas Record, the plaintiff’s suit faults Bayer with failing to warn patients and health care providers about the risks of using Yaz, in particular the risk of blood clots and pulmonary embolism.

In the case, the plaintiff claims that the blood clots that formed in her lungs were the result of her use of the oral contraceptive, Yaz. Additionally, the plaintiff’s Yaz lawsuit charges the German pharmaceutical company with misleading marketing of their contraceptive drug.

The case was filed in the Eastern District of Texas, and is being heard by U.S. District Judge Rodney Gilstrap.

Carey Danis & Lowe Can Help You

Carey Danis & Lowe represents victims of defective drugs, such as individuals who used Yaz, Yasmin, and Occella. We encourage those who believe that they have been injured by one of these oral contraceptives to use the many resources offered by Carey Danis & Lowe, including our Yaz, Yasmin, and Occella resource center, available on our website 24/7.

Carey Danis & Lowe Yaz attorneys welcome you to explore your legal options in a free initial consultation. Share your Yaz story with one of our dedicated attorneys. Also, we can provide you with assistance in filing a Yaz lawsuit.

We also work alongside a team of medical professionals, who are committed to closely listening to your concerns about Yaz and patient safety. Our medical staff are here to allay your concerns and provide you with a clear solution to your medical predicaments.

Contact Carey Danis & Lowe today. Call us at 800.721.2519, or complete a confidential personal injury claim form.

Update June 2012: Yaz & Yasmin Court Information

By | Pharmaceutical litigation, Uncategorized, Yaz/Yasmin

Published June 21, 2012 on LawsuitInformation.org

Yaz Lawsuit Court Info (6/13/12) — Seedol

The latest addition to Yaz Lawsuit news is that attorneys are still taking cases for those whose health was severely affected through the use of this birth control. Yaz, Yasmin and other drospirenone-containing birth controls have been linked to devastating blood clots that can cause young victims to be on blood-thinning medication for the remainder of their lives.

Many Yaz Lawsuits have been pursued for blood-clot related issues like a stroke, pulmonary embolism or deep vein thrombosis. Recent Yaz Lawsuit cases filed have included for those with gallbladder disease or gallbladder failure due to Yaz. Regardless of your side effect, it may be beneficial to speak with a firm that is experienced in settling Yaz & Yasmin lawsuits to see if your situation qualifies for the current Yaz Lawsuit.

Bayer has settled hundreds of Yaz Lawsuits, but it is not too late to begin pursuing compensation for the detrimental health issues you may have after taking Yaz or Yasmin. It is likely that settlements will be made for many of the remaining Yaz Lawsuit cases filed. The situation is also unique in that many experts believe the Yaz Lawsuit may not go to trial phase. The multi-district litigation taking place in the Southern-district of Illinois is continuing to file and settle Yaz and Yasmin side effect lawsuits.

Effects of the Mensing Ruling on Yaz & Yasmin Lawsuits

By | Pharmaceutical litigation, Uncategorized, Yaz/Yasmin

Published June 4, 2012 on LawsuitInformation.org

Yaz Lawsuit and The Mensing Ruling

The Mensing Ruling refers to a ruling by the Supreme Court in the case of Pliva, Inc., et al. v. Mensing which essentially protected generic manufacturers from lawsuits for failure to warn about any side effects of their products beyond the warnings contained on the warning label of the name Brand product of which they are a “copy”.

The ruling does not effect the Yaz Lawsuit or the Yazmin Lawsuit however, it may effect women who took Generics of Yaz and Yazmin even if those generics were sold under brand names.

Yaz Lawsuit not covered under Mensing

Although the Mensing Ruling does not effect the maker of the Brand Name Drugs Yaz and Yasmin from Facing a Yaz Lawsuit or a Yasmin Lawsuit, the Mensing ruling may effect women who took “Branded Generics like Occela, Safyral, Gianvi, Loryna and others. Although all of the drugs were sold under brand names, they were considered generics. This selling of Generics under a brand name would seem to be a contradiction.

The term “Brand and Generic” are terms used to distinguish a “Brand Name” product from a “Generic” copy of that same brand. This contradiction would not be relevant to the Yaz Lawsuit and other drugs listed by the FDA containing Drospirenone if it were not for a ruling commonly known as the “Mensing Ruling” in which the supreme court ruled that the manufacturer of a generic drug could not be held liable for side effects from that drug so long as the generic manufacturer placed the same warning on their generic version of the drug as was placed on the brand name version of the drug.

This ruling does not effect the Yaz Lawsuit or the Yasmin Lawsuit however, the Mensing ruling may effect those who took one of the “Branded Generics” as those may be protected under the Mensing ruling despite the fact that they were sold under Brand Names.

Yaz Lawsuit and Senate Bill

Although the law may never pass, Legislation was presented before the Senate, The Senate bill, S. 2295m titled the “Patient Safety and Generic Labeling Improvement Act” which would allow generic drug manufacturers to put additional warning labels on their products beyond those of the Name Brand of which they are a copy. The Mensing ruling was largely based on the fact that generic manufacturers are not allowed to place warnings on their products beyond or different than those placed on the Brand Name of which they were a copy.

The high court’s reasoning in the Mensing case was largely based on the logic that if a generic manufacturer was not allowed to place a warning on their products that went further than or differed from the Brand Names warnings then they could not be held liable for failing to warn the public of a potential risk associated with their product that was not covered in the warning label of the product.

The Senate Bill was introduced in April 2012 and has to go through a long process before becoming law if it ever does. Until then, individuals that take Generic drugs may have no recourse if they suffer severe side effects from a generic drug that were not covered on the warning label. As previously stated, Yaz and Yasmin, the drugs that are subject to the Yaz Lawsuit and Yasmin Lawsuit, were both sold as Brand Name Drugs therefore, the Mensing ruling nor the Senate Bill effect the Yaz Lawsuit or Yasmin Lawsuit in anyway what so ever.

There may be arguments regarding whether some of the other “Branded Generics” should be afforded the protection of the Mensing ruling considering the fact that these drugs were in fact “Branded” with names like Ocella. It is reasonable to assume that a person taking a drug that has a brand name would believe they are taking a Brand Name drug vs a generic drug. Whether or not this consumer confusion created by generics being sold under brand names will come into play in the over all birth control pill lawsuit is yet to be seen regardless, at least those women who took Yaz and Yasmin will still be able to file a Yaz Lawsuit or a Yazmin Lawsuit without any concern of their suit being tossed out due to the Mensing ruling.

Yaz Lawsuit News Update

By | Pharmaceutical litigation, Uncategorized, Yaz/Yasmin

Published May 18, 2012 on Seedol

Yaz Lawsuit News 05/18/2012: The extension of time to settle Yaz Lawsuits in the Multi District Litigation by the presiding Judge coupled with Bayer releasing information that they intend to settle Yaz Lawsuits without going to trial when possible has led to law firms accepting new clients for the Yaz Lawsuits.

Many Law Firms were wrapping up their Yaz Case Docket in preparation for trial or settlement. Now that Bayer has been given an extension of time the Plaintiff Law Firms representing clients also have more time to take on new clients before sitting down with the defense lawyers representing Bayer to settle their docket of Yaz Lawsuits.

If you took Yaz and suffered a severe side effect it is not too late to have your case taken by a firm experienced with the Yaz Lawsuit. This situation presents an opportunity for those injured by Yaz who have yet to seek legal counsel as it can be very advantageous to have your case handled by a law firm that has a large docket of Yaz Lawsuits already.

Law Firms representing many clients have a strategic advantage over Law Firms with only a few clients as the prospect of going to trial with a Law Firm representing a large number of clients is far more risky for the defense than going to trail with a Law Firm representing a small number of clients.

For more information on getting your Yaz Lawsuit case in the hands of a Law Firm with a large Yaz Lawsuit docket , contact us today.

34 Plaintiffs Fill New Yaz and Yasmin Lawsuit

By | Pharmaceutical litigation, Uncategorized, Yaz/Yasmin

Published May 19, 2012 on Seedol

In addition to the nearly 12,000 Yaz and Yasmin Lawsuits that have been filed a new Yaz Lawsuit and Yasmin Lawsuit was filed in the Superior Court of California, Los Angeles County in late April. This new Y Lawsuit names Bayer Healthcare LLC; Bayer Pharmaceuticals Corporation; Bayer Healthcare Pharmaceuticals Inc.; Berlex Laboratories, Inc.; Berlex, Inc.; Bayer Schering Pharma AG; Bayer AG; McKesson Corporation; Barr Laboratories, Inc; Barr Pharmaceuticals LLC; Teva Pharmaceuticals USA, Inc. and Teva Pharmaceutical Industries Ltd as defendants. The Yaz Lawsuit wsa filed on behalf of approxitmately 34 Plaintiffs.

As with previous Yaz Lawsuits this suit alleges that the Defendants knew and were aware or should have been aware that the PRODUCTS had not been sufficiently tested, was defective in its design and testing, and lacked adequate and sufficient warnings.

The suit also alleges that the Defendants knew or should have known that the PRODUCTS had a potential to, could, and would cause severe and grievous injury and death to the users of said product, and that it was inherently dangerous in a manner that exceeded any purported, inaccurate and downplayed warnings.

The suit in question is bases on numerous allegations other than those listed above with the majority of the allegations in the complaint being centered around the defendants “Failure to Warn” the plaintiffs of the risks associated with the use of Yaz or Yazmin.

If you took Yaz or Yazmin and suffered a blood clot reltated injury such as a DVT, a pulmonary emoblishm, a stroke or other blood clot related injury it is not too late to file a Yaz Lawsuit or Yazmin Lawsuit to be compensated for your medical bills, pain and suffering and other loses. Visit Carey Danis & Lowe to file your claim.